Primary biliary cholangitis trials in France

In France 6 Also abroad 41

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Where
Bobigny, Creteil Cedex, Lille, Lyon Cedex 04, Montpellier Cedex 5, Nancy, Paris, Strasbourg Cedex, Villejuif Cedex
Age
18 years and over
People
402 worldwide
Run by
Gilead Sciences
See details and how to joinNCT06051617 · EU 2024-516525-31-01
Phase 3Taking people
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Where
Clichy, Creteil, Lille, Lyon Cedex 04, Nice, Paris Cedex 13, Poitiers, Toulouse Cedex 3, Villejuif Cedex
Age
18 years and over
People
276 worldwide
Run by
Ipsen
See details and how to joinNCT06016842 · EU 2023-505251-43-00
Phase 3Taking people
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
Where
Creteil, Lyon Cedex 04, Marseille, Montpellier Cedex 5, Pessac, Reims Cedex
Age
18 years to 64 years
People
386 worldwide
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT07216235 · EU 2025-524067-20-00
No phaseTaking people
LEOPARD Training and Validation Data Collection Study
Where
Besançon, Chambray-lès-Tours, Clichy, Créteil, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Pessac, Rennes, Strasbourg, Toulouse, Villejuif
Age
18 years to 70 years
People
4,500 worldwide
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06675604
No phaseTaking people
LEOPARD Prospective Validation Cohort 1
Where
Clichy, Créteil, Montpellier, Paris
Age
18 years to 70 years
People
630 worldwide
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06723275
Phase 3Taking people
Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
Where
Paris
Age
18 years to 80 years
People
108
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06443606